Related Experiment Video
Updated: Feb 6, 2026

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy
Published on: June 29, 2021
Collagen/Heparin Bi-Affinity Multilayer Modified Collagen Scaffolds for Controlled bFGF Release to Improve
Wangping Hao1, Jie Han1,2, Yun Chu1
1Key Laboratory for Nano-Bio Interface Research, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, 215123, P.R. China.
A novel collagen/heparin bi-affinity multilayer delivery system (CHBMDS) enables sustained release of basic fibroblast growth factor (bFGF) for over 35 days. This system significantly enhances angiogenesis, improving therapeutic potential for tissue repair.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Basic fibroblast growth factor (bFGF) is crucial for wound healing and angiogenesis.
- Current delivery systems limit bFGF's clinical application due to poor viability.
- Effective delivery is needed to harness bFGF's therapeutic potential.
Purpose of the Study:
- To develop a collagen/heparin bi-affinity multilayer delivery system (CHBMDS) for sustained bFGF release.
- To evaluate the CHBMDS's efficacy in promoting angiogenesis.
- To enhance the therapeutic outcomes for injured tissues.
Main Methods:
- Fabrication of CHBMDS via alternate deposition of heparin, collagen, and CBD-bFGF.
- Utilizing specific and electrostatic interactions for layer assembly.
- Assessing CBD-bFGF release kinetics and in vivo angiogenesis in SD rats.
Main Results:
- CHBMDS demonstrated sustained localized release of CBD-bFGF for over 35 days.
- Significant enhancement in angiogenesis was observed, with higher density and larger diameter of new blood vessels (≈70 µm).
- The system proved effective in promoting vascularization in subcutaneous tissue.
Conclusions:
- CHBMDS provides a viable and effective strategy for long-term, controlled delivery of bFGF.
- The system shows promise for improving therapeutic efficacy in tissue engineering and regenerative medicine.
- This approach offers a versatile platform for enhancing bFGF-based therapies.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Collagens are the Major Structural Proteins of ECM
Connective tissue proper includes loose...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Electron Affinity
Affinity and Avidity
Mechanism of Angiogenesis

